Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

CUSIP: 03168L105

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / Class A Common Stock, par value $0.01
Shares outstanding
313,041,907
Total 13F shares
97,469,656
Share change
+97,464,899
Total reported value
$1,599,487,071
Price per share
$16.41
Number of holders
163
Value change
+$1,599,409,043
Number of buys
162

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 03168L105?
CUSIP 03168L105 identifies AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2018

As of 30 Jun 2018, Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by 163 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 97,469,656 shares. The largest 10 holders included Fosun International Ltd, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., TPG Group Holdings (SBS) Advisors, Inc., AMERIPRISE FINANCIAL INC, MAVERICK CAPITAL LTD, TCW GROUP INC, and DIMENSIONAL FUND ADVISORS LP. This page lists 163 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2018 vs Q4 2025 Across Filers

Q4 2025 holders
275
Q2 2018 holders
163
Holder diff
-112
Investor Q4 2025 Shares Q2 2018 Shares Share Diff Share Chg % Q4 2025 Value $ Q2 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.